Quantification of Carbon Dioxide Removal at Low Sweep Gas and Blood Flows

Advancement in oxygenator membrane technology has further expanded the boundaries in the clinical application of extracorporeal carbon dioxide removal (ECCO 2 R). Despite the advent of modern poly-4-methyl-1-pentene (PMP) membranes, limited information exists on the performance of these membranes at low sweep gas and blood flows. Moreover, physiological relationships for CO 2 removal at these flows are less explored. Hence, CO 2 removal was quantified in an in vitro setting using a PMP membrane oxygenator. ECCO 2 R was performed using a .8 m 2 surface pediatric oxygenator in an in vitro setting with freshly drawn single-source porcine blood. In this setting, low blood flows of either 200 or 350 mL/min were generated, with sweep gas flow rates of 100, 200, and 400 mL/min, respectively. CO 2 transfer ranged from 14.05 ± 4.35 mL/min/m 2 to 18.76 ± 4.26 mL/min/m 2 at a sweep gas to a blood flow ratio of .5:1 to 2:1 ( p < .01). Decreasing this ratio i.e., increasing the blood flow (.5:1.75 and 2:1.75) resulted in a lower CO 2 transfer of 10.00 ± 4.77 mL/min/m 2 to 16.87 ± 5.09 mL/min/m 2 , which was still statistically significant ( p < .01). Alternatively, decreasing the sweep gas to blood flow ratio, while maintaining a constant gas flow, did not show a significant increase in CO 2 extraction ( p > .05). At these test parameters, an increase in sweep gas improved the CO 2 transfer, whereas an increase in blood flow resulted in a lower CO 2 transfer. These results indicate that CO 2 removal in low-flow ECCO 2 R is mainly sweep gas flow driven. Although these settings might not be applicable for clinical use, this study gives tangible information about the important factor involved in ECCO 2 R.